Accessibility Menu
LifeStance Health Group Stock Quote

LifeStance Health Group (NASDAQ: LFST)

$7.15
(-1.3%)
-0.10
Price as of March 2, 2026, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$7.15
Daily Change
(-1.3%) $0.10
Day's Range
$7.08 - $7.29
Previous Close
$7.15
Open
$7.15
Beta
N/A
Volume
N/A
Average Volume
2,233,607
Market Cap
$2.8B
Market Cap / Employee
$7.14M
52wk Range
$3.74 - $8.30
Revenue
N/A
Gross Margin
0.29%
Dividend Yield
N/A
EPS
$0.03
CAPs Rating
N/A
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

LifeStance Health Group Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LFST-8.34%N/AN/A-67%
S&P+15.57%+80.16%+12.49%+62%

LifeStance Health Group Company Info

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

News & Analysis

Financial Health

General

Q4 2025YOY Change
Revenue$382.20M17.4%
Gross Profit$112.86M19.1%
Gross Margin29.53%0.4%
Market Cap$2.74B-2.9%
Market Cap / Employee$249.85K0.0%
Employees11K7.3%
Net Income$11.67M264.1%
EBITDA$31.88M103.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$248.64M60.9%
Accounts Receivable$95.71M-27.4%
Inventory00.0%

Liabilities

Q4 2025YOY Change
Long Term Debt$414.48M-3.3%
Short Term Debt$60.04M5.9%

Ratios

Q4 2025YOY Change
Return On Assets0.43%3.0%
Return On Invested Capital-8.94%-1.1%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$46.65M-16.7%
Operating Free Cash Flow$57.56M-7.6%

Valuation

MetricQ4 2025YoY Change
Price to Earnings281.60-
Price to Book1.761.381.451.83-6.51%
Price to Sales2.031.521.561.92-14.88%
Price to Tangible Book Value-67.33-85.25-631.06146.90-368.82%
Price to Free Cash Flow TTM25.4116.6517.9224.85-24.52%
Enterprise Value to EBITDA189.20196.25111.8392.83-53.84%
Free Cash Flow Yield3.9%6.0%5.6%4.0%32.48%
Return on Equity-2.5%-1.1%-0.6%0.7%-116.30%
Total Debt$482.08M$474.25M$473.64M$474.52M-2.20%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.